Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

L N Sansom

Showing results (1-10 of 42) with videos related to

Pageof 5
Sort By:
Biochemical Pharmacology|November 6, 1991
The inhibition of drug oxidation by anhydroerythromycin, an acid degradation product of erythromycinI Stupans, L N Sansom
The Journal of Pharmacology and Experimental Therapeutics|March 1, 1981
Interaction between phenytoin, 5-(p-hydroxyphenyl)-5-phenylhydantoin and valproate in the ratT D O'Leary, L N Sansom
Biopolymers|January 1, 1971
Interaction of proflavine and 9-aminoacridine with DNA at temperatures below and above the melting temperatureD O Jordan, L N Sansom
Drug Safety|April 1, 1995
What is the true clinical significance of plasma protein binding displacement interactions?L N Sansom, A M Evans
Pharmacology & Therapeutics|April 1, 1994
Bioequivalence requirements for generic productsR L Nation, L N Sansom
European Journal of Clinical Pharmacology|January 1, 1979
Comparative bioavailability of a microcrystalline theophylline tablet and uncoated aminophylline tabletsL N Sansom, R W Milne, D Cooper
Xenobiotica; the Fate of Foreign Compounds in Biological Systems|November 1, 1995
Cyclophosphamide administered repeatedly to the male rat and as a single dose to the female rat. Its effects on hepatic and pulmonary P450 and associated enzymesM T Angley, L N Sansom, I Stupans
Biopharmaceutics & Drug Disposition|November 1, 1989
Lack of effect of co-trimoxazole on the pharmacokinetics of orally administered theophyllineK F Lo, L Nation, L N Sansom
Bone|November 1, 1995
Human pharmacokinetics of tiludronateL N Sansom, J Necciari, J F Thiercelin
The Medical Journal of Australia|August 23, 1980
Interaction between phenytoin and valproateL N Sansom, R C Beran, G J Schapel
Pageof 5

Showing results (1-10 of 42) with videos related to

Sort By:
Pageof 5
Biochemical Pharmacology|November 6, 1991
The inhibition of drug oxidation by anhydroerythromycin, an acid degradation product of erythromycinI Stupans, L N Sansom
The Journal of Pharmacology and Experimental Therapeutics|March 1, 1981
Interaction between phenytoin, 5-(p-hydroxyphenyl)-5-phenylhydantoin and valproate in the ratT D O'Leary, L N Sansom
Biopolymers|January 1, 1971
Interaction of proflavine and 9-aminoacridine with DNA at temperatures below and above the melting temperatureD O Jordan, L N Sansom
Drug Safety|April 1, 1995
What is the true clinical significance of plasma protein binding displacement interactions?L N Sansom, A M Evans
Pharmacology & Therapeutics|April 1, 1994
Bioequivalence requirements for generic productsR L Nation, L N Sansom
European Journal of Clinical Pharmacology|January 1, 1979
Comparative bioavailability of a microcrystalline theophylline tablet and uncoated aminophylline tabletsL N Sansom, R W Milne, D Cooper
Xenobiotica; the Fate of Foreign Compounds in Biological Systems|November 1, 1995
Cyclophosphamide administered repeatedly to the male rat and as a single dose to the female rat. Its effects on hepatic and pulmonary P450 and associated enzymesM T Angley, L N Sansom, I Stupans
Biopharmaceutics & Drug Disposition|November 1, 1989
Lack of effect of co-trimoxazole on the pharmacokinetics of orally administered theophyllineK F Lo, L Nation, L N Sansom
Bone|November 1, 1995
Human pharmacokinetics of tiludronateL N Sansom, J Necciari, J F Thiercelin
The Medical Journal of Australia|August 23, 1980
Interaction between phenytoin and valproateL N Sansom, R C Beran, G J Schapel
Pageof 5